Navamedic ASA (NAVA) – Strategy, SWOT and Corporate Finance Report

Navamedic ASA (NAVA) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Navamedic ASA (Navamedic) is a pharmaceutical company developing, producing and marketing medicines and related products. It offers products in branded generics, specialty pharma, medical nutrition and consumer health. In specialty pharma and consumer health, the company focuses on specific categories like women’s health, cardiology, gastro, obesity, cough and cold, urology, dermatology, wound care and pain relief. Navamedic offers products to patients, hospitals, wholesalers and pharmacy chains in the Nordic, Benelux, Baltic countries and other European nations including UK and Greece. The company distributes more than 40 products supplied by several international pharmaceutical manufacturers through its subsidiary Navamedic AB, in the European market. Navamedic is headquartered in Oslo, Norway.

Scope

• Detailed information on Navamedic ASA required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Navamedic ASA in the form of a SWOT analysis

• An in-depth view of the business model of Navamedic ASA including a breakdown and examination of key business segments

• News about Navamedic ASA, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Navamedic ASA and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Navamedic ASA as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Navamedic ASAs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Napp Pharmaceuticals Ltd

Photocure ASA

Arctic Bioscience AS

AxiCorp GmbH

Unimedic AB

Laerdal Medical AS

Bluefish Pharma Incentive AB

AxiCorp GmbH

Vingmed AS

Unimedic AB

Photocure ASA

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Navamedic ASA - Key Facts

Navamedic ASA - Key Employees

Navamedic ASA - Key Employee Biographies

Navamedic ASA - Key Operational Employees

Navamedic ASA - Major Products and Services

Navamedic ASA - History

Navamedic ASA - Company Statement

Navamedic ASA - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Navamedic ASA - Business Description

Product Category: Branded generics

Overview

Performance

Product Category: Consumer health

Overview

Performance

Product Category: Medical nutrition

Overview

Performance

Product Category: Others

Performance

Product Category: Specialty pharma

Overview

Performance

Geographical Segment: Denmark

Performance

Geographical Segment: Finland

Performance

Geographical Segment: Norway

Performance

Geographical Segment: Other countries

Performance

Geographical Segment: Sweden

Performance

Navamedic ASA - Corporate Strategy

Navamedic ASA - SWOT Analysis

SWOT Analysis - Overview

Navamedic ASA - Strengths

Navamedic ASA - Weaknesses

Navamedic ASA - Opportunities

Navamedic ASA - Threats

Navamedic ASA - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Navamedic ASA, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 11, 2023: Navamedic announces results for the first quarter of 2023

May 11, 2023: Navamedic ASA: Notice of Annual General Meeting

May 08, 2023: Navamedic invitation to 2023 1st quarter presentation

Apr 28, 2023: Navamedic ASA: Annual Report for 2022

Feb 16, 2023: Navamedic Announces Q4 2022 financial results

Feb 13, 2023: Navamedic Announces Invitation to 2022 4th quarter presentation

Nov 01, 2022: Navamedic announces Q3 2022 financial results

Oct 25, 2022: Navamedic announces Invitation to 2022 third quarter presentation

Oct 20, 2022: Navamedic ASA launches ForlaxGO - an innovative on-the-go product for the treatment of constipation

Aug 12, 2022: Navamedic ASA: Q2 and first half 2022 financial results

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Navamedic ASA, Key Facts

Navamedic ASA, Key Employees

Navamedic ASA, Key Employee Biographies

Navamedic ASA, Key Operational Employees

Navamedic ASA, Major Products and Services

Navamedic ASA, History

Navamedic ASA, Other Locations

Navamedic ASA, Subsidiaries

Navamedic ASA, Key Competitors

Navamedic ASA, Ratios based on current share price

Navamedic ASA, Annual Ratios

Navamedic ASA, Annual Ratios (Cont…1)

Navamedic ASA, Annual Ratios (Cont…2)

Navamedic ASA, Interim Ratios

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Navamedic ASA, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Navamedic ASA, Performance Chart (2018 – 2022)

Navamedic ASA, Ratio Charts

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports